GB0101313D0 - Assay - Google Patents

Assay

Info

Publication number
GB0101313D0
GB0101313D0 GBGB0101313.5A GB0101313A GB0101313D0 GB 0101313 D0 GB0101313 D0 GB 0101313D0 GB 0101313 A GB0101313 A GB 0101313A GB 0101313 D0 GB0101313 D0 GB 0101313D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0101313.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0101313.5A priority Critical patent/GB0101313D0/en
Publication of GB0101313D0 publication Critical patent/GB0101313D0/en
Priority to EP02715521A priority patent/EP1352084A2/en
Priority to PCT/GB2002/000214 priority patent/WO2002058323A2/en
Priority to JP2002558684A priority patent/JP2004531697A/ja
Priority to AU2002225169A priority patent/AU2002225169A1/en
Priority to US10/466,391 priority patent/US20040146953A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0101313.5A 2001-01-18 2001-01-18 Assay Ceased GB0101313D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0101313.5A GB0101313D0 (en) 2001-01-18 2001-01-18 Assay
EP02715521A EP1352084A2 (en) 2001-01-18 2002-01-18 Method for identifying modulators of bace
PCT/GB2002/000214 WO2002058323A2 (en) 2001-01-18 2002-01-18 Method for identifying modulators of bace
JP2002558684A JP2004531697A (ja) 2001-01-18 2002-01-18 アッセイ
AU2002225169A AU2002225169A1 (en) 2001-01-18 2002-01-18 Method for identifying modulators of bace
US10/466,391 US20040146953A1 (en) 2001-01-18 2002-01-18 Assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101313.5A GB0101313D0 (en) 2001-01-18 2001-01-18 Assay

Publications (1)

Publication Number Publication Date
GB0101313D0 true GB0101313D0 (en) 2001-02-28

Family

ID=9907053

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0101313.5A Ceased GB0101313D0 (en) 2001-01-18 2001-01-18 Assay

Country Status (6)

Country Link
US (1) US20040146953A1 (https=)
EP (1) EP1352084A2 (https=)
JP (1) JP2004531697A (https=)
AU (1) AU2002225169A1 (https=)
GB (1) GB0101313D0 (https=)
WO (1) WO2002058323A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0101312D0 (en) 2001-01-18 2001-02-28 Glaxo Group Ltd Assay
US20060287501A1 (en) * 2002-10-31 2006-12-21 Pieris Proteolab Ag Soluble truncated polypeptides of the nogo-a protein
JP2005145837A (ja) * 2003-11-12 2005-06-09 Institute Of Physical & Chemical Research アルツハイマー病の診断方法
CA2549956C (en) * 2003-12-22 2016-04-12 Glaxo Group Limited Immunoglobulins
ES2400287T3 (es) * 2005-03-14 2013-04-08 High Point Pharmaceuticals, Llc Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
US7087399B1 (en) * 1999-05-13 2006-08-08 Scios, Inc. β-secretase and modulation of β-secretase activity
IL150566A0 (en) * 2000-01-12 2003-02-12 Univ Yale Nucleic acids and polypeptides and nogo-receptor proteins

Also Published As

Publication number Publication date
EP1352084A2 (en) 2003-10-15
AU2002225169A1 (en) 2002-07-30
WO2002058323A2 (en) 2002-07-25
US20040146953A1 (en) 2004-07-29
WO2002058323A3 (en) 2003-07-17
JP2004531697A (ja) 2004-10-14

Similar Documents

Publication Publication Date Title
HUP0303809A3 (en) Assay system
EP1470421A4 (en) BIOLOGICAL ASSAY FOR RAPIDLY DETECTING THE PRESENCE OF PRIONS
GB0120126D0 (en) Assay device
EP1442299A4 (en) TRIAL
GB0012860D0 (en) Assay
GB0115777D0 (en) Assay
PL370539A1 (en) Assay
GB0008784D0 (en) Assay
GB0120589D0 (en) Assay
GB0101313D0 (en) Assay
GB0121440D0 (en) Assay
GB0003902D0 (en) Assay
GB0005894D0 (en) Assay
GB0127132D0 (en) Assay
GB0010960D0 (en) Assay
GB0101312D0 (en) Assay
GB0200428D0 (en) Assay
GB0001703D0 (en) Assay
GB0025804D0 (en) Assay
GB0105362D0 (en) Assay
GB0100290D0 (en) Assay
GB0023239D0 (en) Assay
GB0013561D0 (en) Assay
GB0003898D0 (en) Assay
GB0019242D0 (en) Assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)